Suppr超能文献

600 余位活体亲属供肾者的长期随访:单中心经验。

Long-Term Follow-up of Over 600 Living Related Kidney Donors: Single-Center Experience.

机构信息

From the Department of Nephrology, Başkent University Faculty of Medicine, Ankara, Turkey.

出版信息

Exp Clin Transplant. 2022 Mar;20(Suppl 1):17-19. doi: 10.6002/ect.MESOT2021.O4.

Abstract

OBJECTIVES

Kidney transplant is the treatment of choice in patients with end-stage renal disease because it offers improved survival and better quality of life. Although most epidemiologic studies have suggested that living kidney donors have a minimal lifetime risk of developing end-stage renal disease, long-term complications and physiologic and psychologic sequelae resulting from donation remain unclear. Here, we examined the long-term results of living-related kidney donors who donated kidneys at the Başkent University Ankara Hospital over the past 25 years.

MATERIALS AND METHODS

We were able to examine 607 kidney transplant donors (mean age of 52.03 ± 11.54 years) who were seen at our center from 1986 to 2021 and who agreed to a general health evaluation. Collected data included donor age, sex, blood type, body mass index, duration after donation, blood pressure measurements, biochemical parameters, abdominal ultrasonograph for size, structure, and renal blood flow of the solitary kidney, comorbid conditions, chronic drug use, and surgical procedures after donation.

RESULTS

Mean time after donation was 10.4 ± 3.2 years. Twenty-four donors (3.9%) were diagnosed with diabetes and 21 (3.4%) with thyroid disease, 64 (10.5%) developed hypertension, and 48 (8.8%) developed atherosclerotic cardiovascular disease. Obesity was found to be an increasing problem in our donor population, with 174 (28.6%) developing mild to moderate obesity (body mass index >25 kg/m2). Older age, obesity, smoking, and hyperlipidemia were found to be the major and independent risk factors of both hypertension and atherosclerotic cardiovascular disease in donors. None of our donors developed endstage renal disease.

CONCLUSIONS

Obesity and hypertension were the most common comorbidities that developed in our kidney donor population. Our principle is to avoid unrelated and nondirected donors because of the possible long-term complications. Unrelated donors may be desperate if a family member needs donation in the future.

摘要

目的

肾移植是终末期肾病患者的治疗选择,因为它能提高生存率和生活质量。尽管大多数流行病学研究表明,活体肾捐献者发生终末期肾病的终身风险极小,但捐赠带来的长期并发症以及生理和心理后遗症仍不清楚。在这里,我们检查了过去 25 年来在安卡拉大学巴什肯特医院进行活体亲属肾移植的供体的长期结果。

材料和方法

我们能够检查 607 名(平均年龄 52.03 ± 11.54 岁)在我们中心就诊的活体肾移植供体,他们在 1986 年至 2021 年期间同意进行全面健康评估。收集的数据包括供体年龄、性别、血型、体重指数、捐赠后时间、血压测量、生化参数、孤立肾脏的大小、结构和血流的腹部超声检查、合并症、慢性药物使用以及捐赠后的手术程序。

结果

平均捐赠后时间为 10.4 ± 3.2 年。24 名(3.9%)供体被诊断患有糖尿病,21 名(3.4%)供体患有甲状腺疾病,64 名(10.5%)患有高血压,48 名(8.8%)患有动脉粥样硬化性心血管疾病。我们发现供体人群中的肥胖问题越来越严重,174 名(28.6%)供体出现轻度至中度肥胖(体重指数 >25 kg/m2)。年龄较大、肥胖、吸烟和高脂血症是供体高血压和动脉粥样硬化性心血管疾病的主要和独立危险因素。我们的供体没有发展为终末期肾病。

结论

肥胖和高血压是我们的肾移植供体人群中最常见的合并症。我们的原则是避免无关和非定向供体,因为可能存在长期并发症。如果未来有家庭成员需要捐赠,无关供体可能会感到绝望。

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验